2. Signaling Pathways
  3. Protein Tyrosine Kinase/RTK
  4. FLT3
  5. FLT3 Control

FLT3 Control

FLT3 Control (1):

Cat. No. Product Name Effect Purity
  • HY-148669B
    (S)-Bleximenib oxalate
    		Control 98.37%
    (S)-Bleximenib (oxalate) is a S-Enantiomer of Bleximenib oxalate (HY-148669A). Bleximenib (JNJ-75276617) oxalate is an orally active and selective menin-KMT2A inhibitor, with IC50 values of 0.1 nM, 0.045 nM, and ≤0.066 nM for humans, mice, and dogs, respectively. Bleximenib oxalate can inhibit the proliferation and induce apoptosis and differentiation of tumor cells. Bleximenib oxalate can be used in the research of tumors such as leukemia.